据介绍，基于京东健康医疗健康供应链和专业服务资源的优势，京东医美以"严选药械、持证医师、拒 绝套路、透明好价"十六字为核心服务承诺，直击传统医美行业中"假货泛滥、无证行医、过度营销、价 格虚高"等痛点，致力于优化用户体验、升级行业生态。京东医美还在医美行业内首创"上班族友好型门 店"，每天营业时间延长至晚上10点，从而更好地为职场人群提供更高效、便捷的专业轻医美服务。 （编辑 张昕） 本报讯 （记者袁传玺）近日，北京国贸商圈万通中心一层悄然出现了一块插满鲜花的装修围挡。鲜花 散尽，"京东首家自营医美店即将开业"的字样赫然出现。据知情人士透露，作为京东医美首个独立门 店，京东医美（国贸店）将于10月中旬正式对外营业。 尽管目前仍处于装修阶段，京东医美（国贸店）的预售活动却已提前引爆市场。记者从京东健康方面了 解到，自9月11日开始京东医美（国贸店）"300元无门槛开业礼券"活动上线以来，短短3天用户共领券 近1800张，预售成交额突破100万元，并仍在快速增长。 事实上，这并不是京东医美首次出现在公众视野中。今年7月份，京东健康体检中心（亦庄店）医疗美 容科正式对外营业。两个月以来，凭借高品质专业服务、透明定价 ...

Core Insights - The Ministry of Commerce and other departments have issued a notification outlining 19 measures to expand service consumption, indicating a shift from strategic positioning to practical implementation [1] - The measures include exploring the establishment of spring and autumn breaks for primary and secondary schools, increasing service consumption time for tourism, and supporting cross-industry IP cooperation and the introduction of foreign sports events [1] - Analysts believe that the combination of clear subsidy directions and financial support will stimulate the IP economy, event economy, and AI+ consumption, while also providing subsidies to residents from the demand side and reducing costs and improving efficiency from the supply side [1] Industry Analysis - The CSI Hong Kong Stock Connect Consumption Theme Index includes a range of new consumption leaders, with service-oriented consumption accounting for over 50%, covering sectors such as cultural tourism, dining, sports goods, medical beauty, and freshly brewed tea [1] - The current rolling price-to-earnings ratio of the index is 22 times, positioned at the 24.5% percentile since its launch in 2020, indicating emerging investment value [1] - The E Fund Hong Kong Stock Connect Consumption ETF (513070) has the lowest management fee rate of 0.15% per year among stock ETFs and supports T+0 trading, providing investors with opportunities to capitalize on service consumption investments [1]

Core Insights - The 25th China International Investment and Trade Fair (CITIF) held in Xiamen, Fujian, established a "Cross-Strait Integration Development Zone" to facilitate business opportunities for Taiwanese enterprises [1][2] - The event featured over 120 delegations from various countries and regions, showcasing the importance of cross-strait economic and trade exchanges [1][3] Group 1: Event Highlights - The exhibition area covered 120,000 square meters, with more than 100 investment promotion activities conducted [1] - The "Cross-Strait Integration Development Zone" was themed "New Integration, Connecting Two Sides, Creating the Future," covering 500 square meters to display the achievements of cross-strait economic cooperation [2] - Taiwanese companies showcased innovative products, such as Morita's medical beauty products and Dongya Machinery's oil-free air compressors, emphasizing their technological advancements [2] Group 2: Economic Cooperation - Fujian has actively built a "Cross-Strait Integration Development Demonstration Zone," becoming a hub for cross-strait exchanges and economic cooperation [3] - The province has ranked first in the number of newly established Taiwanese enterprises and actual use of Taiwanese capital for three consecutive years [3] - The trade volume between Fujian and Taiwan is projected to grow by 4.2% in 2024, indicating a positive trend in cross-strait economic relations [3] Group 3: Business Opportunities - The "Five Provinces' Promotion of Business Environment to Taiwan" event facilitated project exchanges between Taiwanese businesses and five provinces, highlighting the potential for collaboration [4] - Taiwanese entrepreneurs expressed interest in leveraging the vast mainland market and unique regional resources for business growth [4] - The CITIF serves as a critical platform for Taiwanese enterprises to integrate into the mainland's industrial and supply chains, enhancing cross-strait economic exchanges [5][6]

Core Insights - JD Health is set to open its second self-operated medical beauty store in the Guomao area of Beijing in mid-October, following the launch of its first store in Yizhuang [1] - The Guomao store is the first independent store under JD Medical Beauty, with a larger area compared to the Yizhuang store [1] - JD Medical Beauty has launched a promotional campaign offering a "300 yuan no-threshold opening gift voucher," significantly reducing prices for various products, which has attracted considerable user interest [1] Summary by Categories Store Launch - JD Medical Beauty's Guomao store will officially open in mid-October, marking the second self-operated store after the Yizhuang location [1] - The Guomao store is noted to be larger in scale than the Yizhuang store, indicating a strategic expansion [1] Promotional Activities - A promotional campaign featuring a "300 yuan no-threshold opening gift voucher" has been initiated, leading to competitive pricing for products [1] - For instance, the price of the HiTi 2.5 voucher is set at 99 yuan, while the market price is generally above 500 yuan [1] - The campaign has seen significant engagement, with nearly 1,800 vouchers claimed and pre-sale transaction amounts exceeding 1 million yuan within three days of launch [1] Customer Engagement - The first week of service appointments for the Guomao store is nearly fully booked, indicating strong demand and customer interest [1] - There is anticipation regarding the potential opening of more JD Medical Beauty stores in the future [1]

Group 1 - The core viewpoint emphasizes the importance of focusing on high-quality companies in the "emotional consumption" theme amid a consumer recovery backdrop [1] - The report highlights four main investment themes: gold and jewelry, offline retail, cosmetics, and medical aesthetics [1] Group 2 - For gold and jewelry, companies with differentiated product offerings and deep consumer insights are recommended [1] - In offline retail, attention is drawn to enterprises that adapt to trends and actively explore transformations, such as supermarkets, department stores, and chain businesses [1] - The cosmetics sector should focus on high-quality domestic beauty brands that excel in high-growth niche markets and continuously enhance their capabilities [1] - In the medical aesthetics field, companies with differentiated product pipelines are highlighted as potential investment opportunities [1]

Group 1 - The core viewpoint emphasizes the importance of focusing on high-quality companies in the "emotional consumption" theme amid the backdrop of consumer recovery [1] Group 2 - Investment focus areas include: 1. Gold and jewelry sector, highlighting brands with differentiated product strength and deep consumer insights [1] 2. Offline retail sector, emphasizing companies that adapt to trends and actively explore transformations [1] 3. Cosmetics sector, focusing on high-quality domestic beauty brands that excel in high-growth niche markets and continuously iterate their capabilities [1] 4. Medical aesthetics sector, concentrating on manufacturers with differentiated product pipelines [1]

Core Viewpoint - The entry of the company into offline light medical beauty clinics has led to a public rift between upstream and downstream players in the medical beauty industry, revealing long-standing grievances over interests [2][3]. Financial Performance - The total revenue of SOYOUNG CLINIC reached 144 million yuan, marking a year-on-year increase of 426.1%, and has become the largest revenue source for the group [2][12]. - The company's total revenue for the second quarter was 378.7 million yuan, down 7% year-on-year, with a net loss of 36 million yuan compared to a net profit of 18.9 million yuan in the same period last year [12]. Business Strategy - The company has launched its self-operated light medical beauty chain, SOYOUNG CLINIC, with plans to expand from 33 stores to 50 by the end of 2025 [2][3]. - The management believes that self-revolution is a strength, despite facing resistance from some partner institutions [2][6]. Industry Dynamics - The transition from an online platform to a direct competitor has caused trust issues with former partners, leading to a trend of "de-SOYOUNG-ization" among medical beauty institutions [5][6]. - The company has faced accusations of "eating from both sides" by competing with its own partners, which has resulted in some partners withdrawing from collaboration [5][11]. Market Competition - The opening of new clinics has sparked conflicts with existing partners, including a major client that threatened to withdraw advertising spending if the new clinic opened nearby [4][5]. - The company has initiated a price war, offering services at significantly lower prices than competitors, which has drawn criticism from upstream suppliers [11]. Operational Insights - The company claims that its self-operated clinics and platform services are complementary rather than competitive, focusing on different market segments [6][12]. - Despite claims of separation, there are indications that the platform may still direct traffic to its own clinics, raising questions about the integrity of its operations [8][9].

Core Viewpoint - The report from Kaiyuan Securities emphasizes the importance of focusing on leading companies that align with the theme of "emotional consumption" as consumer recovery takes center stage, highlighting four key investment lines [1] Group 1: Investment Lines - Gold and Jewelry: Attention should be given to gold and jewelry brands that possess differentiated product capabilities and deep consumer insights [1] - Offline Retail: Retail enterprises (supermarkets, department stores, chains) that actively adapt and explore trends should be monitored [1] - Cosmetics: High-quality domestic beauty brands that are deeply engaged in high-growth niche markets and continuously evolving their capabilities are of interest [1] - Medical Aesthetics: Companies with differentiated product lines in the medical aesthetics sector should be focused on [1]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The report highlights that the retail sector is experiencing steady growth, with a year-on-year increase of 4.6% in retail sales from January to August 2025, amounting to 3,239.06 billion [3][4] - In August 2025, retail sales reached 396.68 billion, reflecting a year-on-year growth of 3.4%, slightly below the expected 3.8% [3][4] - The report emphasizes a strong performance in optional consumption categories, particularly gold and jewelry, which saw a year-on-year increase of 16.8% in August [4][6] Summary by Sections Retail Sales Performance - The total retail sales for January to August 2025 were 3,239.06 billion, with August sales at 396.68 billion, showing a year-on-year increase of 3.4% [3][4] - Essential goods like grain and oil showed resilience, while optional categories like gold and jewelry performed exceptionally well [4] Online vs. Offline Channels - Online retail sales from January to August 2025 reached 999.28 billion, growing by 9.6%, with physical goods online sales at 809.64 billion, up by 6.4% [5] - Offline retail growth has shown a marginal slowdown across various formats, with supermarkets and convenience stores growing by 4.9% and 6.6% respectively [5] Investment Recommendations - The report suggests focusing on high-quality companies in the "emotional consumption" theme, particularly in four main areas: 1. Gold and jewelry brands with differentiated product offerings [6] 2. Retail enterprises adapting to market trends [6] 3. High-quality domestic beauty brands [6] 4. Medical beauty product manufacturers with unique pipelines [6]

Group 1 - The ongoing dispute over the "AestheFill" product involves Aimei Ke's subsidiary REGEN Biotech, which has been restricted from selling the product in mainland China until arbitration is resolved [1][2] - Aimei Ke confirmed that the recent decision is a procedural matter and does not constitute a final arbitration ruling, indicating that REGEN may still sell AestheFill in mainland China [2][3] - The product AestheFill has been out of stock for two months, affecting downstream medical beauty institutions, although Aimei Ke attributes the shortage to distributor sales strategies [2][3] Group 2 - AestheFill has been rebranded as "Zhen Ai Su Fei," but many institutions still refer to it as "Ai Su Fei," leading to confusion in the market [2][3] - There is a significant price discrepancy between the two names, with "Ai Su Fei" priced as low as 8,700 yuan per 200mg unit, while "Zhen Ai Su Fei" is priced around 21,000 yuan for the same quantity [3] - The ability of Aimei Ke to stabilize the sales and pricing of AestheFill remains uncertain and will require further observation [3]